Taken together, our findings suggested that the Sohlh1/SFRP1/Wnt/β‐catenin signalling pathway represented one of the key molecular networks involved in the regulation of GSLC biology in glioma. The gene discussed is SFRP1; the disease is central nervous system cancer.